Brian Kim

Search results

• New formulation of FDA-approved drug shows encouraging results for treating a common itch condition

  Mark Lebwohl & Brian Kim

  8/02/23 → 11/05/23

  4 items of Media coverage

  Press/Media

• Mount Sinai to expand research training program in skin biology with support from $1.3 million T32 grant

  Mark Lebwohl, Sarah Millar, Emma Guttman & Brian Kim

  3/04/23

  3 items of Media coverage

  Press/Media

• Mount Sinai Awarded Prestigious $1.3 Million Grant to Expand Research Training Program in Skin Biology

  Mark Lebwohl, Sarah Millar, Emma Guttman & Brian Kim

  3/04/23

  3 items of Media coverage

  Press/Media

• A Hidden Crisis: The Need for Treatments in Notalgia Paresthetica

  Brian Kim

  28/03/23

  2 items of Media coverage

  Press/Media

• New Formulation of FDA-Approved Drug Shows Encouraging Results for Treating a C…

  Mark Lebwohl & Brian Kim

  16/02/23

  1 item of Media coverage

  Press/Media

• Notalgia paresthetica: Difelikefalin helps upper-back itch, but with side effects

  Mark Lebwohl & Brian Kim

  13/02/23

  1 item of Media coverage

  Press/Media

• Winter is tough on skin. Experts offer tips to ease itchiness.

  Mark Lebwohl & Brian Kim

  13/02/23

  1 item of Media coverage

  Press/Media

• Cara Therapeutics (CARA) Announces Results from the KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Notalgia Paresthetica Published in NEJM

  Brian Kim

  9/02/23

  3 items of Media coverage

  Press/Media

• News Drug Shows Promise Against “Unreachable Itch” Condition Difelikefalin – a drug approved by the US Food and Drug Administration (FDA) for treating itching associated with chronic kidney disease (CKD) – has shown promise against the nerve disorder nota

  Brian Kim

  9/02/23

  1 item of Media coverage

  Press/Media

• Potential Notalgia Paresthetica Breakthrough: Oral Difelikefalin May Curb Persistent Itch

  Mark Lebwohl & Brian Kim

  9/02/23

  1 item of Media coverage

  Press/Media

• New Formulation of FDA-Approved Drug Shows Encouraging Results for Treating a Common Itch Condition in Phase 2 Clinical Trial

  Mark Lebwohl & Brian Kim

  9/02/23

  9 items of Media coverage

  Press/Media

• Difelikefalin Helps Upper Back Itch, but With Side Effects

  Mark Lebwohl & Brian Kim

  9/02/23

  1 item of Media coverage

  Press/Media

• New Formulation of FDA-Approved Drug Shows Encouraging Results for Treating a Common Itch Condition in Phase 2 Clinical Trial.

  Mark Lebwohl & Brian Kim

  9/02/23

  1 item of Media coverage

  Press/Media

• Difelikefalin Improves Itch Intensity in Notalgia Paresthetica

  Brian Kim

  9/02/23

  84 items of Media coverage

  Press/Media

• Difelikefalin Improves Itch Intensity in Notalgia Paresthetica; However, more frequent headache, dizziness, constipation, increased urine output seen for patients receiving difelikefalin versus placebo.

  Brian Kim

  9/02/23

  1 item of Media coverage

  Press/Media

• Cara Therapeutics Announces Results From The KOMFORT Phase 2 Trial Of Oral Difelikefalin For The Treatment Of Pruritus In Notalgia Paresthetica Published In The New England Journal Of Medicine

  Brian Kim

  8/02/23

  1 item of Media coverage

  Press/Media

• Mount Sinai: New Formulation of FDA-Approved Drug Shows Encouraging Results for Treating a Common Itch Condition

  Mark Lebwohl & Brian Kim

  8/02/23

  1 item of Media coverage

  Press/Media

• Cara Therapeutics Announces Results from the KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Notalgia Paresthetica Published in the New England Journal of Medicine

  Brian Kim

  8/02/23

  43 items of Media coverage

  Press/Media

• New Formulation of FDA-Approved Drug Shows Encouraging Results for Treating a Common Itch Condition

  Mark Lebwohl & Brian Kim

  7/02/23

  1 item of Media coverage

  Press/Media

• Icahn School of Medicine at Mount Sinai Researchers Discuss Findings in Immunology (Skin-homing basophils and beyond)

  Brian Kim

  11/01/23

  1 item of Media coverage

  Press/Media

• How to Soothe Itchy Skin; The creams that can offer lasting relief

  Mark Lebwohl & Brian Kim

  1/01/23

  1 item of Media coverage

  Press/Media

• Important News About PFAS; The widespread use of these dangerous chemicals needs to stop

  Mark Lebwohl & Brian Kim

  1/01/23

  1 item of Media coverage

  Press/Media

• eLife Latest: Welcoming our newest editors

  Brian Kim

  8/09/22

  1 item of Media coverage

  Press/Media

• -Cara Therapeutics to Host Virtual Notalgia Paresthetica Event on September 20, 2022

  Brian Kim

  25/08/22

  2 items of Media coverage

  Press/Media

• Cara Therapeutics To Host Virtual Notalgia Paresthetica Event On September 20, 2022

  Brian Kim

  24/08/22

  1 item of Media coverage

  Press/Media